Moderna study suggests COVID-19 vaccine protects against delta variant, others

Moderna’s COVID-19 vaccine shows promise in protecting against virus variants — including the particularly worrisome delta strain, the drugmaker said Tuesday.

The company said it ran a lab study on the blood of eight people one week after they received their second dose of Moderna’s immunization. The results indicated that the vaccinated group had produced antibodies against variants of the deadly virus — including India’s highly contagious delta mutation, as well as the country’s kappa variant and South Africa’s beta strain, the Massachusetts-based drugmaker said.